European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess
long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate
to severe alopecia areata. Patients from European sites who previously completed a qualifying
CTP-543 clinical trial may participate in this study.